| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
MATTHEWS, N.C.—Microwave chemistry specialist CEM announced it has partnered with its Indian distributor Niulab Equipment to open a microwave chemistry division on the subcontinent. The move is expected to help CEM further penetrate an Indian market that is seeing strong growth both in indigenous biotechnology and pharmaceutical development and as a services provider.
 
"India's scientific community is growing rapidly and many of the world's largest pharmaceutical companies either have laboratory facilities in the country or outsource to Indian companies," said Michael J. Collins, CEM president and CEO. "Our relationships with Niulab and some of the top chemists using microwave technology in India and give us a unique understanding of the market and its needs."
 
The division, which currently has a staff of four, will offer a full-line of microwave systems, applications and expertise. The companies expect the team to expand to 10 within the next two years.

About the Author

Related Topics

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A blue x-ray style image of a human body is shown with the liver illuminated in orange against a dark blue background.

Harnessing liver-on-a-chip models for drug safety

Discover how researchers leverage microphysiological systems in toxicology studies.  
A person wearing a white lab coat types on a laptop with various overlaid enlarged files shown with plus signs on file folders floating over the laptop screen with a clinical lab shown in the background in grey and white tones.

Enhancing bioanalytical studies with centralized data management

Learn how researchers can improve compliance and efficiency with advanced LIMS solutions.
A 3D-rendered digital illustration of a molecular structure floating among red blood cells in a bloodstream environment.

Explained: How are metabolite biomarkers improving drug discovery and development?

By offering a rich source of insights into disease and drugs, metabolite biomarkers are at the forefront of therapeutic exploration.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue